Advertisement
Screener

ARALEZ PHARMACEUTICALS INC. Form DEF 14A: Definitive proxy statement

ARALEZ PHARMACEUTICALS INC. Form DEF 14A: Definitive proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2018-05-18: Form DEF 14A; Period of report 2018-06-29; Description DEF 14A; Document a2235749zdef14a.htm.
  • 2017-03-23: Form DEF 14A; Period of report 2017-05-03; Description DEF 14A; Document a17-8680_1def14a.htm.
  • 2016-05-09: Form DEF 14A; Period of report 2016-06-16; Description DEF 14A; Document a16-10541_2def14a.htm.
FiledFormPeriod of reportDescriptionDocument
2018-05-18DEF 14A2018-06-29DEF 14Aa2235749zdef14a.htm
2017-03-23DEF 14A2017-05-03DEF 14Aa17-8680_1def14a.htm
2016-05-09DEF 14A2016-06-16DEF 14Aa16-10541_2def14a.htm